Harmony Biosciences Files 2024 Annual Report
Ticker: HRMY · Form: 10-K · Filed: 2025-02-25T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Harmony Biosciences dropped its 2024 10-K. Check financials for FY ending 12/31/24.
AI Summary
Harmony Biosciences Holdings, Inc. filed its 2024 10-K on February 25, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, incorporated in Delaware, operates in the pharmaceutical preparations sector. Key financial details and business operations for the period are outlined in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Harmony Biosciences' financial health, strategic initiatives, and risk factors for the past fiscal year, crucial for understanding the company's performance and future outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Harmony Biosciences faces inherent risks related to drug development, regulatory approvals, market competition, and patent expirations.
Key Numbers
- 2024-12-31 — Fiscal Year End (The end date of the reporting period for the 10-K.)
- 2025-02-25 — Filing Date (The date Harmony Biosciences submitted its 10-K to the SEC.)
Key Players & Entities
- Harmony Biosciences Holdings, Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end date
- 2025-02-25 (date) — Filing date of the 10-K
- DE (state) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Harmony Biosciences Holdings, Inc. as indicated in the filing?
The filing indicates Harmony Biosciences Holdings, Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
When did Harmony Biosciences Holdings, Inc. file its 10-K report?
Harmony Biosciences Holdings, Inc. filed its 10-K report on February 25, 2025.
For which fiscal year is this 10-K report?
This 10-K report is for the fiscal year ending December 31, 2024.
In which state was Harmony Biosciences Holdings, Inc. incorporated?
Harmony Biosciences Holdings, Inc. was incorporated in Delaware (DE).
What is the reported business address for Harmony Biosciences Holdings, Inc.?
The business address is 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA 19462.
From the Filing
0001558370-25-001441.txt : 20250225 0001558370-25-001441.hdr.sgml : 20250225 20250225080033 ACCESSION NUMBER: 0001558370-25-001441 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 112 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250225 DATE AS OF CHANGE: 20250225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 25659472 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 10-K 1 hrmy-20241231x10k.htm 10-K HARMONY BIOSCIENCES HOLDINGS, INC._December 31, 2024 http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember 0001802665 FY false 2024 http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#RelatedPartyMember http://fasb.org/us-gaap/2024#RelatedPartyMember http://fasb.org/us-gaap/2024#ProductMember http://fasb.org/us-gaap/2024#ProductMember P3Y P1Y http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent P3Y 0001802665 hrmy:SecSchedule1209AllowanceDistributionFeesDiscountsAndChargebacksMember 2024-01-01 2024-12-31 0001802665 hrmy:SecSchedule1209AllowanceDistributionFeesDiscountsAndChargebacksMember 2023-01-01 2023-12-31 0001802665 hrmy:SecSchedule1209AllowanceDistributionFeesDiscountsAndChargebacksMember 2022-01-01 2022-12-31 0001802665 hrmy:SecSchedule1209AllowanceDistributionFeesDiscountsAndChargebacksMember 2024-12-31 0001802665 hrmy:SecSchedule1209AllowanceDistributionFeesDiscountsAndChargebacksMember 2023-12-31 0001802665 hrmy:SecSchedule1209AllowanceDistributionFeesDiscountsAndChargebacksMember 2022-12-31 0001802665 hrmy:SecSchedule1209AllowanceDistributionFeesDiscountsAndChargebacksMember 2021-12-31 0001802665 hrmy:SeniorSecuredDelayedDrawTermLoanMember 2023-12-31 0001802665 hrmy:October2023ShareRepurchaseProgramMember 2024-12-31 0001802665 hrmy:October2023ShareRepurchaseProgramMember 2024-01-01 2024-12-31 0001802665 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001802665 us-gaap:RetainedEarningsMember 2024-12-31 0001802665 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001802665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001802665 us-gaap:RetainedEarningsMember 2023-12-31 0001802665 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001802665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001802665 us-gaap:RetainedEarningsMember 2022-12-31 0001802665 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001802665 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001802665 us-gaap:RetainedEarningsMember 2021-12-31 0001802665 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001802665 us-gaap:CommonStockMember 2024-12-31 0001802665 us-gaap:CommonStockMember 2023-12-31 0001802665 us-gaap:CommonStockMember 2022-12-31 0001802665 us-gaap:CommonStockMember 2021-12-31 0001802665 srt:MinimumMember 2023-01-01 2023-12-31 0001802665 srt:MaximumMember 2023-01-01 2023-12-31 0001802665 srt:MinimumMember 2022-01-01 2022-12-31 0001802665 srt:MaximumMember 2022-01-01 2022-12-31 0001802665 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001802665 us-gaap:RestrictedStockUnitsRSUMember hrmy:TwoThousandSeventeenEquityIncentivePlanAndTwoThousandTwentyIncentiveAwardPlanMember 2024-01-01 2024-12-31 00018026